Page last updated: 2024-08-18

cyclohexanol and 4-hydroxy-n-desmethyltamoxifen

cyclohexanol has been researched along with 4-hydroxy-n-desmethyltamoxifen in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V	1
Ford, BM; Franks, LN; Prather, PL; Radominska-Pandya, A	1

Reviews

1 review(s) available for cyclohexanol and 4-hydroxy-n-desmethyltamoxifen

Article	Year
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. The American journal of psychiatry, 2008, Volume: 165, Issue:10 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride	2008

Article

Year

Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

The American journal of psychiatry, 2008, Volume: 165, Issue:10

Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride

2008

Other Studies

1 other study(ies) available for cyclohexanol and 4-hydroxy-n-desmethyltamoxifen

Article	Year
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development. PloS one, 2016, Volume: 11, Issue:12 Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Isomerism; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tamoxifen	2016

Article

Year

Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development.

PloS one, 2016, Volume: 11, Issue:12

Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Isomerism; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tamoxifen

2016